Improving Safety of Cardiovascular Implantable Electronic Devices in Veterans

提高退伍军人心血管植入电子设备的安全性

基本信息

项目摘要

Background: This proposal is intended to support the career development of Sanket Dhruva, MD, MHS, a Staff Cardiologist at the San Francisco VA and Assistant Professor of Medicine at the University of California, San Francisco into an independent VA health services researcher with the training and experience necessary to conduct innovative research and develop interventions that improve safety of Veterans with cardiovascular implantable electronic devices (CIEDs: pacemakers and implantable cardioverter defibrillators [ICDs]). Even though more than 10% of the 55,000 Veterans followed by VA have suffered CIED-related complications, there has not been any systematic evaluation to identify failed CIED leads using VA’s data systems. Significance/Impact: This research will close Dr. Dhruva’s knowledge gaps in biostatistics, data science, and qualitative methods, enabling him to generate actionable, high-quality evidence to inform VA cardiac electrophysiologists to implant the safest devices in Veterans. This research will also enable him to identify CIED leads that have already been implanted in Veterans but are at risk for failure, thereby informing strategies to avoid clinical sequelae of failure (such as inappropriate shocks and death) for individual Veterans. This proposal is directly aligned with operational priorities set forth in VHA Directive 1189 (published in January 2020) to “monitor the safety of CIEDs,” HSR&D Priorities of a Learning Healthcare System and improving Veteran Quality of Care and Safety, and supports VHA’s priority of becoming a High-Reliability Organization. Innovation: This research is innovative through its application of advanced statistical methods to leverage a comprehensive, longitudinal database of Veterans with CIEDs, the VA National Cardiac Device Surveillance Program (NCDSP), including temporally dense CIED-generated data, to address the large-scale, complex problem of identifying CIED lead failure. Additionally, this research provides information about the unexplored question of physician selection of manufacturer and model of device to implant and the role of safety data. Specific Aims: Aim 1: To compare risk-adjusted failure rates of different cardiovascular implantable electronic device (CIED) lead models among Veterans. H1: We will detect one or more CIED lead models with statistically and clinically significantly higher failure rates when compared to other leads of the same type (e.g. ICD lead when compared to all other ICD leads). Aim 2: To develop risk prediction models of all-cause CIED lead failure among Veterans by applying supervised machine learning methods to repeated measures from CIED remote monitoring data. H2: Risk prediction models will detect lead failure with high discrimination (area under the curve [AUC] ≥0.85) and adequate calibration at 3 months and 12 months post-assessment. Aim 3: To conduct a pilot study to determine the effect of an academic detailing and audit and feedback intervention on the specific CIED lead models implanted in Veterans. H3: Post-intervention, Veterans will more often be implanted with lead models associated with the lowest failure rates. Methodology: Aim 1 will use sequential propensity score-adjusted simulated prospective survival analyses applied to a dataset of the NCDSP linked to VA’s Corporate Data Warehouse and Medicare data. Aim 2 will apply two supervised machine learning techniques, elastic net and random forests, to quarterly patient- generated data from CIEDs to create prediction models. Aim 3 will include qualitative interviews of cardiac electrophysiologists about device selection and the development, implementation, and evaluation of an academic detailing and audit and feedback intervention for cardiac electrophysiologists in 3 VISNs. Implementation: This research will enable Dr. Dhruva to become an independent VA HSR&D investigator who conducts research to improve outcomes for Veterans with CIEDs and those who will receive one in the future.
背景:本提案旨在支持Sanket Dhruva, MD, MHS, a的职业发展

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sanket S Dhruva其他文献

Sanket S Dhruva的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sanket S Dhruva', 18)}}的其他基金

Improving Safety of Cardiovascular Implantable Electronic Devices in Veterans
提高退伍军人心血管植入电子设备的安全性
  • 批准号:
    10312661
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了